ACTU
Actuate Therapeutics
ACTU
ACTU
43 hedge funds and large institutions have $80.5M invested in Actuate Therapeutics in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5.43% less ownership
Funds ownership: 57.17% → 51.74% (-5.4%)
Holders
43
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.08M | |
| 2 | +$580K | |
| 3 | +$568K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$345K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$183K |
Top Sellers
| 1 | -$190K | |
| 2 | -$142K | |
| 3 | -$73.6K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$69.7K |
| 5 |
CPIG
Chicago Partners Investment Group
Chicago,
Illinois
|
-$68.4K |
